Chi-Myst Resolve
- Manufacturer
- Prescription Care LLC
- Effective date
- 2016-05-03
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-05-31 20:22:19
Label at a glance#
ProductChi-Myst Resolve Topical
Active ingredientBUPIVACAINE HYDROCHLORIDE, KETOROLAC TROMETHAMINE, CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S), LIDOCAINE HYDROCHLORIDE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BUPIVACAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| KETOROLAC Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| LIDOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70486-011-00 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-26d0-f424-e053-dadaa90a57ce | Chi-Myst Resolve Topical |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70486-011-00 | Chi-Myst ResolveTopical | 100 mL in 1 BOTTLE, SPRAY | SPRAY, METERED | 100 | 4 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Chi-Myst Resolve Topical
- Chitosan ketorolac bupivacaine lidocaine suspension
- BUPIVACAINE HYDROCHLORIDE
- BUPIVACAINE
- BUPIVACAINE HYDROCHLORIDE ANHYDROUS
- KETOROLAC TROMETHAMINE
- KETOROLAC
- CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S)
- GLYCERIN
- WATER
- LACTIC ACID LACTATE, DL-
- SODIUM HYDROXIDE
- LIDOCAINE HYDROCHLORIDE
- LIDOCAINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70486-011 | 70486-011-00 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BUPIVACAINE HYDROCHLORIDE | 7TQO7W3VT8 | ACTIR |
| KETOROLAC TROMETHAMINE | 4EVE5946BQ | ACTIM |
| CHITOSAN LOW MOLECULAR WEIGHT (20-200 MPA.S) | SBD1A2I75N | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| WATER | 059QF0KO0R | IACT |
| LACTIC ACID LACTATE, DL- | N37QW3EK1L | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| LIDOCAINE HYDROCHLORIDE | V13007Z41A | ACTIR |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 01be57c5-897d-45f5-982f-37518a4965a1 | 0eeee2c4-704b-4c87-8dd0-5a400b748e97 | 2016-05-03 | 01be57c5-897d-45f5-982f-37518a4965a1 0eeee2c4-704b-4c87-8dd0-5a400b748e97 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
